MYX 2.49% $4.70 mayne pharma group limited

fair price $8.22, page-6

  1. 167 Posts.
    lightbulb Created with Sketch. 95
    Definitely agree with some of above, but IMO the consolidation was the right thing to do, although should have been paired with a small holding buy-back. Aim to reduce small holders and the admin costs associated.

    Maybe this hurt share price initially; almost always does; but by now the fundamentals are driving the action. I.e. we would have corrected if we had a reason to.

    Also - I didn't agree with DIV and Cap Return (later cancelled), but for long-term holders and tax effect; the company should have done the Cap Return not DIV. Some of the core business was sold.

    This would have given max benefit to long-term holders with higher buying as reduces their purchase price. Given the current $cash position, we have a couple months till 1/2 year report and that will show us if the cash burn has stopped. If it has, the $ returned to investors was probably the correct decision.

    just my 2c
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.